Dense core vesicle markers in CSF and cortical tissues of patients with Alzheimer’s disease

Background: New fluid biomarkers for Alzheimer's disease (AD) that reveal synaptic and neural network dysfunctions are needed for clinical practice and therapeutic trial design. Dense core vesicle (DCV) cargos are promising cerebrospinal fluid (CSF) indicators of synaptic failure in AD patients. How...

Full description

Bibliographic Details
Authors: Barranco Muñoz, Neus; Plá, Virginia; Alcolea, Daniel; Sánchez-Domínguez, Irene; Fischer-Colbrie, Reiner; Ferrer, Isidro; Lleó Bisa, Alberto; Aguado, Fernando
Format: Article
Status:Published version
Publication date:2021
Country:España
Institution:Universidad de Barcelona
Repository:Dipòsit Digital de la UB
OAI Identifier:oai:diposit.ub.edu:2445/180534
Online Access:https://hdl.handle.net/2445/180534
Access Level:Open access
Keyword:Marcadors bioquímics
Malaltia d'Alzheimer
Biochemical markers
Alzheimer's disease
_version_ 1878733841641766912
author Barranco Muñoz, Neus
author2 Plá, Virginia
Alcolea, Daniel
Sánchez-Domínguez, Irene
Fischer-Colbrie, Reiner
Ferrer, Isidro
Lleó Bisa, Alberto
Aguado, Fernando
author2_role author
author
author
author
author
author
author
author_browse Aguado, Fernando
Alcolea, Daniel
Barranco Muñoz, Neus
Ferrer, Isidro
Fischer-Colbrie, Reiner
Lleó Bisa, Alberto
Plá, Virginia
Sánchez-Domínguez, Irene
author_facet Barranco Muñoz, Neus
Plá, Virginia
Alcolea, Daniel
Sánchez-Domínguez, Irene
Fischer-Colbrie, Reiner
Ferrer, Isidro
Lleó Bisa, Alberto
Aguado, Fernando
author_role author
collection Dipòsit Digital de la UB
description Background: New fluid biomarkers for Alzheimer's disease (AD) that reveal synaptic and neural network dysfunctions are needed for clinical practice and therapeutic trial design. Dense core vesicle (DCV) cargos are promising cerebrospinal fluid (CSF) indicators of synaptic failure in AD patients. However, their value as biomarkers has not yet been determined. Methods: Immunoassays were performed to analyze the secretory proteins prohormone convertases PC1/3 and PC2, carboxypeptidase E (CPE), secretogranins SgIII and SgII, and Cystatin C in the cerebral cortex (n = 45, provided by Bellvitge University Hospital) and CSF samples (n = 66, provided by The Sant Pau Initiative on Neurodegeneration cohort) from AD patients (n = 56) and age-matched controls (n = 55). Results: In AD tissues, most DCV proteins were aberrantly accumulated in dystrophic neurites and activated astrocytes, whereas PC1/3, PC2 and CPE were also specifically accumulated in hippocampal granulovacuolar degeneration bodies. AD individuals displayed an overall decline of secretory proteins in the CSF. Interestingly, in AD patients, the CSF levels of prohormone convertases strongly correlated inversely with those of neurodegeneration markers and directly with cognitive impairment status. Conclusions: These results demonstrate marked alterations of neuronal-specific prohormone convertases in CSF and cortical tissues of AD patients. The neuronal DCV cargos are biomarker candidates for synaptic dysfunction and neurodegeneration in AD.
eu_rights_str_mv openAccess
format article
id ES_5e1026741d5b2e452dfe8b4e069e9b2d
institution Universidad de Barcelona
instname_str Universidad de Barcelona
network_acronym_str ES
network_name_str España
oai_identifier_str oai:diposit.ub.edu:2445/180534
publishDate 2021
publishDateSort 2021
publisher Springer Science and Business Media LLC
publisherStr Springer Science and Business Media LLC
reponame_str Dipòsit Digital de la UB
spelling Dense core vesicle markers in CSF and cortical tissues of patients with Alzheimer’s disease Barranco Muñoz, Neus Plá, Virginia Alcolea, Daniel Sánchez-Domínguez, Irene Fischer-Colbrie, Reiner Ferrer, Isidro Lleó Bisa, Alberto Aguado, Fernando Marcadors bioquímics Malaltia d'Alzheimer Biochemical markers Alzheimer's disease Background: New fluid biomarkers for Alzheimer's disease (AD) that reveal synaptic and neural network dysfunctions are needed for clinical practice and therapeutic trial design. Dense core vesicle (DCV) cargos are promising cerebrospinal fluid (CSF) indicators of synaptic failure in AD patients. However, their value as biomarkers has not yet been determined. Methods: Immunoassays were performed to analyze the secretory proteins prohormone convertases PC1/3 and PC2, carboxypeptidase E (CPE), secretogranins SgIII and SgII, and Cystatin C in the cerebral cortex (n = 45, provided by Bellvitge University Hospital) and CSF samples (n = 66, provided by The Sant Pau Initiative on Neurodegeneration cohort) from AD patients (n = 56) and age-matched controls (n = 55). Results: In AD tissues, most DCV proteins were aberrantly accumulated in dystrophic neurites and activated astrocytes, whereas PC1/3, PC2 and CPE were also specifically accumulated in hippocampal granulovacuolar degeneration bodies. AD individuals displayed an overall decline of secretory proteins in the CSF. Interestingly, in AD patients, the CSF levels of prohormone convertases strongly correlated inversely with those of neurodegeneration markers and directly with cognitive impairment status. Conclusions: These results demonstrate marked alterations of neuronal-specific prohormone convertases in CSF and cortical tissues of AD patients. The neuronal DCV cargos are biomarker candidates for synaptic dysfunction and neurodegeneration in AD. Springer Science and Business Media LLC https://hdl.handle.net/2445/180534
spellingShingle Dense core vesicle markers in CSF and cortical tissues of patients with Alzheimer’s disease
Barranco Muñoz, Neus
Marcadors bioquímics
Malaltia d'Alzheimer
Biochemical markers
Alzheimer's disease
status_str publishedVersion
title Dense core vesicle markers in CSF and cortical tissues of patients with Alzheimer’s disease
title_full Dense core vesicle markers in CSF and cortical tissues of patients with Alzheimer’s disease
title_fullStr Dense core vesicle markers in CSF and cortical tissues of patients with Alzheimer’s disease
title_full_unstemmed Dense core vesicle markers in CSF and cortical tissues of patients with Alzheimer’s disease
title_short Dense core vesicle markers in CSF and cortical tissues of patients with Alzheimer’s disease
title_sort Dense core vesicle markers in CSF and cortical tissues of patients with Alzheimer’s disease
topic Marcadors bioquímics
Malaltia d'Alzheimer
Biochemical markers
Alzheimer's disease
topic_facet Marcadors bioquímics
Malaltia d'Alzheimer
Biochemical markers
Alzheimer's disease
url https://hdl.handle.net/2445/180534